![](/img/cover-not-exists.png)
Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial
Zhang, Xinxin, Liu, Li, Yao, Yazhou, Gong, Sha, Wang, Mengchang, Xi, Jieying, Chen, Limei, Wei, Suhua, Zhang, Huiyun, Zhao, Chenyang, Wang, HuaiyuVolume:
21
Journal:
Trials
DOI:
10.1186/s13063-019-3983-2
Date:
December, 2020
File:
PDF, 879 KB
2020